| __timestamp | Sarepta Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 305409000 |
| Thursday, January 1, 2015 | 75043000 | 377080000 |
| Friday, January 1, 2016 | 83749000 | 432829000 |
| Sunday, January 1, 2017 | 122682000 | 496079000 |
| Monday, January 1, 2018 | 207761000 | 557616000 |
| Tuesday, January 1, 2019 | 284812000 | 658498000 |
| Wednesday, January 1, 2020 | 317875000 | 770456000 |
| Friday, January 1, 2021 | 282660000 | 840100000 |
| Saturday, January 1, 2022 | 451421000 | 944700000 |
| Sunday, January 1, 2023 | 481871000 | 1136600000 |
| Monday, January 1, 2024 | 1464300000 |
Data in motion
In the competitive landscape of biotechnology, understanding financial trends is crucial. Over the past decade, Vertex Pharmaceuticals and Sarepta Therapeutics have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Vertex's SG&A expenses surged by approximately 272%, reflecting its aggressive expansion and market penetration strategies. In contrast, Sarepta's expenses grew by about 878%, indicating its rapid scaling and investment in administrative capabilities.
These trends highlight the differing strategies of these biotech giants, with Vertex focusing on steady growth and Sarepta on rapid expansion.
Selling, General, and Administrative Costs: Pfizer Inc. vs Vertex Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Opthea Limited
Cost Management Insights: SG&A Expenses for Vertex Pharmaceuticals Incorporated and Ultragenyx Pharmaceutical Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc. Trends and Insights